Cell Aging May Predict Future Disease

Plasma proteomic models of more than 40 cell types were associated with incident Alzheimer's disease, amyotrophic lateral sclerosis, cancer, and mortality across three large cohorts.

By
Andrea Surnit
June 18, 2026
4 min

Conexiant

At a Glance

Category	Detail
Condition	Cellular Aging and Associated Diseases
Key Mechanisms	Plasma proteomic signatures linked to biological age of cell types.
Target Population	Patients analyzed from Global Neurodegeneration Proteomics Consortium, UK Biobank, and 1946 National Survey of Health and Development.
Care Setting	Observational study across multiple cohorts.

Key Highlights

Extreme astrocyte aging linked to a 12.6-fold higher likelihood of developing Alzheimer's disease.
Extreme skeletal myocyte aging associated with a 12.7-fold higher likelihood of developing amyotrophic lateral sclerosis.
Cell-specific aging signatures correlated with future cancer and chronic diseases.
Patients with extreme aging across more than 20 cell types had approximately 34% survival over 15 years.
Youthful immune and neuronal aging signatures associated with more favorable survival outcomes.

Guideline-Based Recommendations

Diagnosis

Utilize plasma proteomic data to estimate biological age of cell types.

Management

Consider cellular aging signatures for risk stratification in age-related diseases.

Monitoring & Follow-up

Assess plasma proteomic profiles for ongoing evaluation of cellular aging.

Risks

Extreme cellular aging correlates with increased risk of neurodegenerative diseases, cancer, and chronic conditions.

Patient & Prescribing Data

Predominantly older and White cohorts.

Noninvasive assessment of cell type-specific biological aging may identify patients at elevated risk.

Clinical Best Practices

Incorporate proteomic profiling in routine assessments for aging-related disease risk.
Monitor cellular aging across multiple cell types for comprehensive risk evaluation.